These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25230231)

  • 21. Structure-Based Drug Discovery of
    Bucknell SJ; Ator MA; Brown AJH; Brown J; Cansfield AD; Cansfield JE; Christopher JA; Congreve M; Cseke G; Deflorian F; Jones CR; Mason JS; O'Brien MA; Ott GR; Pickworth M; Southall SM
    J Med Chem; 2020 Jul; 63(14):7906-7920. PubMed ID: 32558564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
    Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
    Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Drugs for Preventing Migraines.
    Aschenbrenner DS
    Am J Nurs; 2019 May; 119(5):22. PubMed ID: 31033548
    [No Abstract]   [Full Text] [Related]  

  • 25. Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism.
    ter Haar E; Koth CM; Abdul-Manan N; Swenson L; Coll JT; Lippke JA; Lepre CA; Garcia-Guzman M; Moore JM
    Structure; 2010 Sep; 18(9):1083-93. PubMed ID: 20826335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcitonin Gene-Related Peptide (CGRP) Antagonists and Their Use in Migraines.
    Henson B; Hollingsworth H; Nevois E; Herndon C
    J Pain Palliat Care Pharmacother; 2020 Mar; 34(1):22-31. PubMed ID: 31763951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
    Edvinsson L; Eftekhari S; Salvatore CA; Warfvinge K
    Mol Cell Neurosci; 2011 Jan; 46(1):333-9. PubMed ID: 21040789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcitonin gene-related peptide (CGRP): a new target for migraine.
    Russo AF
    Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CGRP receptor antagonists: toward a novel migraine therapy.
    Salvatore CA; Kane SA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1671-80. PubMed ID: 21466447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Presence of Calcitonin Gene-Related Peptide and Its Receptors in Rat, Pig and Human Brain: Species Differences in Calcitonin Gene-Related Peptide Pharmacology.
    Warfvinge K; Edvinsson L; Pickering DS; Sheykhzade M
    Pharmacology; 2019; 104(5-6):332-341. PubMed ID: 31484177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
    Bigal ME; Walter S; Rapoport AM
    Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking.
    Manoukian R; Sun H; Miller S; Shi D; Chan B; Xu C
    J Headache Pain; 2019 Apr; 20(1):44. PubMed ID: 31039731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CGRP Pathway in Migraine as a Viable Target for Therapies.
    Edvinsson L
    Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGRP receptor antagonism and migraine therapy.
    Edvinsson L; Warfvinge K
    Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitonin gene-related peptide (CGRP) receptor antagonists: Heterocyclic modification of a novel azepinone lead.
    Luo G; Jiang XJ; Chen L; Conway CM; Gulianello M; Kostich W; Keavy D; Signor LJ; Chen P; Davis C; Whiterock VJ; Schartman R; Widmann KA; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2021 Jul; 43():128077. PubMed ID: 33932522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture.
    Takhshid MA; Poyner DR; Chabot JG; Fournier A; Ma W; Zheng WH; Owji AA; Quirion R
    Br J Pharmacol; 2006 Jun; 148(4):459-68. PubMed ID: 16702994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants.
    Do TP; Al-Saoudi A; Ashina M
    Rev Neurol (Paris); 2021 Sep; 177(7):827-833. PubMed ID: 34294458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CGRP - a target for acute therapy in migraine: Clinical data.
    Messina R; Goadsby PJ
    Cephalalgia; 2019 Mar; 39(3):420-427. PubMed ID: 29616830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine.
    Bell IM
    J Med Chem; 2014 Oct; 57(19):7838-58. PubMed ID: 24960305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
    Durham PL; Vause CV
    CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.